openPR Logo
Press release

Medicare Drug Plan Comparison Tool Helps Seniors Save

Best Medicare Drug Plan Comparison Tool

Best Medicare Drug Plan Comparison Tool

The typical senior who switches their Medicare drug plan coverage saves between $500 and $700 yearly reports the American Association for Medicare Supplement Insurance (AAMSI).

Medicare Open Enrollment currently underway allows millions of Medicare beneficiaries to find the best drug plan coverage for the coming year. According to Jesse Slome, director of the Medicare-focused organization, a majority of seniors do not take advantage of the opportunity to review and lock in a potentially better plan for the coming year.

"Prescription drug plans typically change each January and those changes can mean you'll pay more in 2023," says Slome. "Medicare mandates that plans give you the chance to review changes and, if you want, find a drug plan that will save you money, get better coverage or both."

Those who take advantage of the opportunity can easily save significant dollars in 2023, the Association director notes. The organization reports that average savings among those who switched plans last year amounted to between $500 and $700.

The American Association for Medicare Supplement Insurance makes available access to a free online drug plan comparison tool. "Consumers do not have to enter any personal information other than their Zip Code to use the tool," Slome adds. "It's completely private and compares over 4,700 plans to find the best one in your area."

Access to the Medicare drug plan comparison tool can be accessed on the Association's website at https://www.medicaresupp.org/best-medicare-drug-plans-2023/.

Slome advises that entering information on the various prescription drugs you take will yield the best 2023 price comparison.

AAMSI
32504 Carrie Place
Westlake Village, CA 91361

Established in 1998, the American Association for Medicare Supplement Insurance advocates for the importance of consumer awareness and supports insurance and financial professionals who market Medicare insurance solutions. Visit their website for more information at https://medicaresupp.org.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Medicare Drug Plan Comparison Tool Helps Seniors Save here

News-ID: 2776470 • Views:

More Releases from American Association for Medicare Supplement Insurance

Association Announces Senior Travel Discount Offers
Association Announces Senior Travel Discount Offers
A special 2024 $100 senior discount with two leading tour operators has been announced by the American Association for Medicare Supplement Insurance. "Seniors are back to traveling the globe and this savings offer has been well received," explains Jesse Slome, director of the senior-focused insurance organization. Slome, himself, has just returned from a three-week tour to Japan. The special discount enables seniors booking a first-time land tour or cruise with either Grand
Medicare Insurance Association Reports Significant Increase In Website Traffic
Medicare Insurance Association Reports Significant Increase In Website Traffic
Seniors accessing the Find A Medicare Insurance Agent online directory hosted by the American Association for Medicare Supplement Insurance increased significantly according to the organization. "There was an 87.3 percent increase in overall traffic during the just concluded Medicare Annual Enrollment Period (AEP)," reports Jesse Slome, director of the Medicare information advocacy organization. "This marked a record high, attributable to the number of seniors shopping for Medicare coverage during AEP." The Medicare
2024 Medicare Drug Plan Premium Costs Vary Widely For Seniors
2024 Medicare Drug Plan Premium Costs Vary Widely For Seniors
A senior in Houston will pay monthly premiums as little as 50-cents for their 2024 stand-alone Medicare prescription drug plan coverage. Or, they could pay as much as $108.30 monthly according to just-released data from the American Association for Medicare Supplement Insurance (AAMSI). "Costs for your 2024 Medicare drug plan coverage will vary widely depending on where you live and the plan you choose," reports Jesse Slome, director of the organization.
Tips Help Seniors Compare Medicare Supplement Insurance Plans
Tips Help Seniors Compare Medicare Supplement Insurance Plans
Choosing the right Medicare insurance plan is one of the most complex decisions made by seniors according to the American Association for Medicare Supplement Insurance (AAMSI). "Seniors can literally have 100 different plans available and choosing the wrong plan can impact their healthcare and pocketbook," explains Jesse Slome, director of the Medicare information advocacy organization. "While Medicare allows people to switch plans, some decisions can be irreversible." To help consumers make better

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug